147 related articles for article (PubMed ID: 29719610)
1. A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells.
Jalota A; Kumar M; Das BC; Yadav AK; Chosdol K; Sinha S
Oncotarget; 2018 Apr; 9(26):18351-18366. PubMed ID: 29719610
[TBL] [Abstract][Full Text] [Related]
2. Synergistic increase in efficacy of a combination of 2-deoxy-D-glucose and cisplatin in normoxia and hypoxia: switch from autophagy to apoptosis.
Jalota A; Kumar M; Das BC; Yadav AK; Chosdol K; Sinha S
Tumour Biol; 2016 Sep; 37(9):12347-12358. PubMed ID: 27306214
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cells.
Yan YR; Xie Q; Li F; Zhang Y; Ma JW; Xie SM; Li HY; Zhong XY
Neuropathology; 2014 Apr; 34(2):128-34. PubMed ID: 24112388
[TBL] [Abstract][Full Text] [Related]
4. HIF-2α mediates a marked increase in migration and stemness characteristics in a subset of glioma cells under hypoxia by activating an Oct-4/Sox-2-Mena (INV) axis.
Bhagat M; Palanichamy JK; Ramalingam P; Mudassir M; Irshad K; Chosdol K; Sarkar C; Seth P; Goswami S; Sinha S; Chattopadhyay P
Int J Biochem Cell Biol; 2016 May; 74():60-71. PubMed ID: 26923292
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
Yang W; Wei J; Guo T; Shen Y; Liu F
Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
[TBL] [Abstract][Full Text] [Related]
6. Glioma cells suppress hypoxia-induced endothelial cell apoptosis and promote the angiogenic process.
Ezhilarasan R; Mohanam I; Govindarajan K; Mohanam S
Int J Oncol; 2007 Mar; 30(3):701-7. PubMed ID: 17273772
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia.
Zhu H; Wang D; Zhang L; Xie X; Wu Y; Liu Y; Shao G; Su Z
Oncol Rep; 2014 Sep; 32(3):935-42. PubMed ID: 24994549
[TBL] [Abstract][Full Text] [Related]
8. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.
Yang DI; Chen SD; Yang YT; Ju TC; Xu JM; Hsu CY
Br J Pharmacol; 2004 Mar; 141(6):988-96. PubMed ID: 14980978
[TBL] [Abstract][Full Text] [Related]
9. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
10. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.
Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH
Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic Microenvironment Induces EMT and Upgrades Stem-Like Properties of Gastric Cancer Cells.
Guo J; Wang B; Fu Z; Wei J; Lu W
Technol Cancer Res Treat; 2016 Feb; 15(1):60-8. PubMed ID: 25601854
[TBL] [Abstract][Full Text] [Related]
12. Cardiac glycosides suppress the maintenance of stemness and malignancy via inhibiting HIF-1α in human glioma stem cells.
Lee DH; Cheul Oh S; Giles AJ; Jung J; Gilbert MR; Park DM
Oncotarget; 2017 Jun; 8(25):40233-40245. PubMed ID: 28410215
[TBL] [Abstract][Full Text] [Related]
13. Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib.
Kardosh A; Soriano N; Pyrko P; Liu YT; Jabbour M; Hofman FM; Schönthal AH
J Biomed Sci; 2007 Sep; 14(5):647-62. PubMed ID: 17440835
[TBL] [Abstract][Full Text] [Related]
14. CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells.
Lehnus KS; Donovan LK; Huang X; Zhao N; Warr TJ; Pilkington GJ; An Q
Int J Oncol; 2013 Mar; 42(3):1011-7. PubMed ID: 23340741
[TBL] [Abstract][Full Text] [Related]
15. Cycling hypoxia induces chemoresistance through the activation of reactive oxygen species-mediated B-cell lymphoma extra-long pathway in glioblastoma multiforme.
Chen WL; Wang CC; Lin YJ; Wu CP; Hsieh CH
J Transl Med; 2015 Dec; 13():389. PubMed ID: 26711814
[TBL] [Abstract][Full Text] [Related]
16. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
17. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
[TBL] [Abstract][Full Text] [Related]
18. Let-7g-5p inhibits epithelial-mesenchymal transition consistent with reduction of glioma stem cell phenotypes by targeting VSIG4 in glioblastoma.
Zhang XH; Qian Y; Li Z; Zhang NN; Xie YJ
Oncol Rep; 2016 Nov; 36(5):2967-2975. PubMed ID: 27634309
[TBL] [Abstract][Full Text] [Related]
19. CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells.
Maeda K; Ding Q; Yoshimitsu M; Kuwahata T; Miyazaki Y; Tsukasa K; Hayashi T; Shinchi H; Natsugoe S; Takao S
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27367674
[TBL] [Abstract][Full Text] [Related]
20. Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules.
Zhu T; Li X; Luo L; Wang X; Li Z; Xie P; Gao X; Song Z; Su J; Liang G
J Transl Med; 2015 Nov; 13():356. PubMed ID: 26563263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
